Show simple item record

177Lu-[DOTA0,Tyr3] octreotate therapy in iodine refractory thyroid cancer: Comparison of dosimetry with therapy of thyroid cancer and neuroendocrine tumors

dc.contributor.authorDemirci, E.
dc.contributor.authorOcak, M.
dc.contributor.authorKanmaz, B.
dc.contributor.authorYeyin, N.
dc.contributor.authorKabasakal, L.
dc.contributor.authorAygun, A.
dc.contributor.authorToklu, T.
dc.contributor.authorSelcuk, N.
dc.date.accessioned2021-03-03T21:05:34Z
dc.date.available2021-03-03T21:05:34Z
dc.identifier.citationYeyin N., Demirci E., Toklu T., Kabasakal L., Aygun A., Ocak M., Selcuk N., Kanmaz B., "177Lu-[DOTA0,Tyr3] octreotate therapy in iodine refractory thyroid cancer: Comparison of dosimetry with therapy of thyroid cancer and neuroendocrine tumors", 25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Milan, İtalya, 27 - 31 Ekim 2012, cilt.39
dc.identifier.othervv_1032021
dc.identifier.otherav_5d61c613-c7ea-4844-8854-1f50433b5229
dc.identifier.urihttp://hdl.handle.net/20.500.12627/65375
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectNükleer Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectKlinik Tıp
dc.subjectRADYOLOJİ, NÜKLEER TIP ve MEDİKAL GÖRÜNTÜLEME
dc.title177Lu-[DOTA0,Tyr3] octreotate therapy in iodine refractory thyroid cancer: Comparison of dosimetry with therapy of thyroid cancer and neuroendocrine tumors
dc.typeBildiri
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume39
dc.contributor.firstauthorID140401


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record